425: Strive, Semler Scientific Announce Merger Communication

Strive, Inc. reposted a communication on X.com regarding its proposed business combination with Semler Scientific, Inc.

Summary

• Strive, Inc. filed a Form 425 communication related to its proposed business combination with Semler Scientific, Inc.
• The communication was originally reposted on X.com by Ben Werkman, Chief Investment Officer of Strive, Inc., on December 18, 2025.
• The filing includes a cautionary statement regarding forward-looking statements concerning the proposed transaction, its strategic and financial benefits, timing, and integration.
• Investors and stockholders are urged to read the Registration Statement on Form S-4, Information Statement/Proxy Statement/Prospectus, and other relevant SEC filings for important information about the companies and the proposed transaction.
• The communication clarifies that it does not constitute an offer to sell or a solicitation of an offer to buy securities or a solicitation of any vote of approval.

Sentiment

Score: 5

Explanation: The filing is neutral, primarily serving as a procedural communication for a proposed merger, outlining potential benefits while heavily emphasizing a comprehensive list of associated risks and forward-looking statement disclaimers.

Positives

• The proposed transaction is expected to yield strategic and financial benefits for the combined company.
• Management anticipates a positive impact on the combined company's future financial performance.

Risks

• The merger agreement between Strive and Semler Scientific could be terminated due to various events, changes, or circumstances.
• The proposed transaction may not close as expected or at all if closing conditions are not met on a timely basis.
• Legal proceedings may be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected or at all.
• Risks are associated with the implementation of Bitcoin treasury strategies and exposure to Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and regulatory changes could impact the realization of benefits.
• The integration of the two companies may be more difficult, time-consuming, or costly than anticipated.
• The proposed transaction may be more expensive or take longer to complete than expected due to unforeseen factors.
• Management's attention may be diverted from ongoing business operations and opportunities during the merger process.
• Strive's issuance of additional shares of its Class A common stock in connection with the transaction will cause dilution.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships may occur.
• Changes in Strive's or Semler Scientific's share price may occur before the closing of the transaction.
• Other unknown or unpredictable factors could harm the results of Strive, Semler Scientific, or the combined company.

Future Outlook

Management expresses expectations for strategic and financial benefits from the proposed transaction, including a positive impact on the combined company's future financial performance, successful integration of businesses, and timely closing of the transaction. However, these are forward-looking statements subject to significant risks and uncertainties.

Management Comments

• Ben Werkman, Chief Investment Officer of Strive, Inc., reposted the communication on X.com on December 18, 2025, in connection with the proposed business combination.

Industry Context

The mention of risks associated with Bitcoin and other digital assets, alongside the implementation of Bitcoin treasury strategies, indicates that the combined entity may have significant exposure or strategic interest in the evolving digital asset industry. This aligns with a broader trend of companies exploring or integrating digital assets into their financial strategies, which carries both opportunities and unique regulatory and market volatility risks.

Legal Proceedings

• There is a risk of legal proceedings being instituted against Strive, Semler Scientific, or the combined company in the future.

Stakeholder Impact

• Shareholders of Strive will experience dilution due to the issuance of additional Class A common stock for the transaction.
• Semler Scientific stockholders are urged to read the Information Statement/Proxy Statement/Prospectus to make informed voting or investment decisions regarding the proposed transaction.
• Customers of both Strive and Semler Scientific may have adverse reactions to the proposed transaction.
• Employee relationships at both companies could change as a result of the announcement or completion of the proposed transaction.

Next Steps

• Semler Scientific stockholders are required to approve the proposed transaction.
• The proposed transaction needs to close, subject to various conditions.
• The combined businesses will undergo integration post-closing.

Key Dates

Keywords

Merger, Business Combination, Strive Inc., Semler Scientific Inc., SEC Filing, Form 425, Forward-Looking Statements, Bitcoin, Digital Assets, Corporate Governance, Investment